+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Immunohistochemical analysis of nm23 protein expression in malignant bone tumors



Immunohistochemical analysis of nm23 protein expression in malignant bone tumors



Journal Of Cancer Research & Clinical Oncology. 121(11): 667-673



Expression levels of nm23 protein in 72 malignant bone tumors comprising 41 osteosarcomas, 22 chondrosarcomas, 6 Ewing's sarcomas, and 2 malignant fibrous histiocytomas were examined immunohistochemically, using anti-nm23 protein polyclonal antibody, and compared with 51 cases of benign bone tumors or tumor-like lesions. Malignant bone tumors showed significantly higher nm23 protein expression than benign bone tumors or tumor-like lesions (P lt 0.0001). In chondrosarcoma, nm23 expression increased in high-grade tumors (grade I versus grade II and III: P = 0.0229). In the cases of osteosarcoma, however, grade IV osteosarcomas showed decreased expression of nm23 compared with grade III tumors (P = 0.0122). There was no significant relationship between nm23 expression and histological type. nm23 expression had no correlation with metastatic potential in osteosarcoma, although the therapy was not uniform in our cases. Furthermore, in 6 cases of osteosarcoma and 1 case of Ewing's sarcoma, there was no cleat tendency for a decrease of nm23 in the metastatic sites compared with primary sites, as reported in breast cancer. These results showed that, in contrast to reports on breast cancer and experimental models, nm23 protein expression in human bone tumors may be associated with malignant potentiality, except in cases of osteosarcoma.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 008819949

Download citation: RISBibTeXText

PMID: 7593131

DOI: 10.1007/bf01218525


Related references

Prognostic significance of nm23 protein expression in malignant melanoma. An immunohistochemical study. Melanoma Research 7(2): 121-128, 1997

Prognostic significance of nm23-protein expression in malignant melanoma An immunohistochemical study. Pigment Cell Research 0(SUPPL 5): 47, 1996

Expression of nm23 protein in malignant epithelial tumors. Chung-Ang Journal of Medicine 20(4): 377-386, 1995

Immunohistochemical analysis of p53 protein expression in benign and malignant skin tumors using a panel of anti-p53 antibodies. Journal of Korean Medical Science 8(5): 361-366, 1993

Immunohistochemical analysis of nm23 protein expression in thyroid papillary carcinoma and follicular neoplasm. Pathology, Research and Practice 205(2): 83-87, 2008

P53 Accumulation in Malignant Bone Tumors: An Immunohistochemical Analysis of 217 Cases. International Journal of Surgical Pathology 5(1-2): 1-9, 1997

Immunohistochemical expression of nm23 in primary invasive malignant melanoma is predictive of survival outcome. Journal of Pathology 190(2): 157-162, 2000

An immunohistochemical analysis of p53 protein expression in pre-malignant and malignant tissues of the oral cavity. Clinical Otolaryngology & Allied Sciences (oxford). 22(1): 23-29, 1997

Expression of p21 protein in benign and malignant tumors of human colorectum by immunohistochemical stain. Journal of Catholic Medical College 46(4): 1431-1442, 1993

The immunohistochemical study of the expression of nm23 gene protein and P-glycoprotein expression on stomach adenocarcinoma. Chung-Ang Journal of Medicine 21(1): 13-24, 1996

High nm23-H1/NDPK-A expression in Ewing tumors: Paradoxical immunohistochemical reactivity and lack of prognostic significance. International Journal of Cancer 64(2): 104-111, 1995

Expression of matrix metalloproteinases in patients with uterine smooth muscle tumors: an immunohistochemical analysis of MMP-1 and MMP-2 protein expression in leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma. Journal of the Society for Gynecologic Investigation 11(3): 182-186, 2004

nm23-H1 protein immunohistochemical expression in human breast cancer. Oncology Reports 3(1): 183-189, 1996

WT1 expression in benign, borderline and malignant vascular tumors: An immunohistochemical analysis of 67 cases. 2008

An immunohistochemical analysis of NM23 expression in breast cancer. Modern Pathology 9(1): 23A, 1996